Various factors are responsible for the market's growth, such as an increase in the prevalence of age-related macular degeneration across the globe and awareness among the population regarding the disease. An increase in the prevalence of the geriatric population, as they are prone to macular degeneration, is additionally contributing to the growth of the AMD drugs market. https://www.datamintelligence.com/research-report/amd-drugs-market